PFGIA
PEAR

Patriot Financial Group Insurance Agency’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

Patriot Financial Group Insurance Agency’s Portfolio PEAR Stock Details PEAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-500
Closed -$1K – 2083
2022
Q2 		$1K Hold
500
– – ﹤0.01% 1984
2022
Q1 		$3K Hold
500
– – ﹤0.01% 1818
2021
Q4 		$3K Buy
+500
New +$4.46K ﹤0.01% 1902

Other funds holding PEAR

Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
SGA
SB Global Advisers London, United Kingdom $861M AUM 71.72% 1-Year Est. Return
AV
Arboretum Ventures Ann Arbor, Michigan $1.72M AUM 82.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TAA
TB Alternative Assets Grand Cayman, Cayman Islands $623M AUM 154.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PT
Palantir Technologies Denver, Colorado $9.72M AUM 6.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Patriot Financial Group Insurance Agency's PEAR Position: Q3 2022 in Review

Patriot Financial Group Insurance Agency sold out of Pear Therapeutics, Inc. Class A Common Stock (PEAR) in Q3 2022, closing a stake of 500 shares — an estimated $1K sold.

Patriot Financial Group Insurance Agency first reported a position in PEAR in Q4 2021 and held it in 3 quarters. The position peaked at $3K in Q1 2022. 60 funds tracked by Wall St. Rank hold PEAR as of Q3 2022.

  • Patriot Financial Group Insurance Agency reported no remaining Pear Therapeutics, Inc. Class A Common Stock position as of Q3 2022 after selling out during the quarter.
  • Patriot Financial Group Insurance Agency sold 500 Pear Therapeutics, Inc. Class A Common Stock shares in Q3 2022, an estimated $1K.
  • Patriot Financial Group Insurance Agency first reported a position in Pear Therapeutics, Inc. Class A Common Stock in Q4 2021 and held it in 3 quarters.
  • Patriot Financial Group Insurance Agency's Pear Therapeutics, Inc. Class A Common Stock position peaked at $3K in Q1 2022.
  • 60 funds tracked by Wall St. Rank held Pear Therapeutics, Inc. Class A Common Stock as of Q3 2022.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q3 2022, filed 1 Nov 2022.